2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
C17H23N3O3S — CID 167988163
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile (PubChem CID 167988163) has the molecular formula C17H23N3O3S and a molecular weight of 349.46 g/mol. Its IUPAC name is 2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 167988163 |
| Molecular Formula | C17H23N3O3S |
| Molecular Weight | 349.46 g/mol |
| Exact Mass | 349.15 |
| IUPAC Name | 2-[(1-methylsulfonylpyrrolidin-3-yl)methoxy]-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile |
| SMILES | CS(=O)(=O)N1CCC(COc2nc3c(cc2C#N)CCCCC3)C1 |
| InChI | InChI=1S/C17H23N3O3S/c1-24(21,22)20-8-7-13(11-20)12-23-17-15(10-18)9-14-5-3-2-4-6-16(14)19-17/h9,13H,2-8,11-12H2,1H3 |
| InChIKey | GMZXKEKJFWKCMA-UHFFFAOYSA-N |
| XLogP | 1.88 |
| TPSA | 83.29 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 349.46 |
| LogP ≤ 5 | 1.88 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167988163 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.